Dolby Laboratories (DLB) Total Liabilities (2009 - 2026)

Dolby Laboratories (DLB) has reported Total Liabilities for 18 consecutive years, with $563.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 3.07% year-over-year to $563.9 million; the trailing twelve-month figure through Jun 2026 stood at $563.9 million (down 3.07% YoY), and the FY2025 full-year result was $595.8 million, down 4.37% from the prior year.
• Total Liabilities declined to $563.9 million in Q2 2026 per DLB's latest filing, from $622.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $646.0 million in Q1 2025 and bottomed at $438.5 million in Q3 2022.
• Historically, Total Liabilities has averaged $560.9 million across 5 years, with a median of $585.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities surged 38.55% in 2023, then dropped 15.84% in 2024.
• Over 5 years, Total Liabilities stood at $456.0 million in 2022, then increased by 25.71% to $573.2 million in 2023, then increased by 11.92% to $641.6 million in 2024, then slipped by 8.16% to $589.3 million in 2025, then dropped by 4.3% to $563.9 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $563.9 million, $622.4 million, and $589.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.